TipRanks

Notifications

Valens Inks Supply And Distribution Deal With Manitoba Liquor And Lotteries

Cannabis products provider The Valens Company Inc. has entered into a supply and distribution agreement with Manitoba Liquor and Lotteries Corporation. It will distribute products to private retailers with an LGCA-license in Manitoba. This increases its distribution network to five provinces in Canada.

Valens (VLNCF) Chief Executive Officer, Co-Founder and Chair, Tyler Robson, said, “Expanding our domestic distribution capabilities is one of our top strategic initiatives to drive growth this year and beyond.”

Robson added, “Our entry into the Manitoba market takes us a step further toward capturing larger market share and bringing the Valens advantage to consumers in a new province, enabling greater access to our high-quality products across Canada.” (See Valens stock analysis on TipRanks)

The company’s distribution reach now includes Manitoba, British Columbia, Ontario and Saskatchewan, with additional plans underway to add more provinces to its network.

Last month, Canaccord Genuity analyst Shaan Mir reiterated a Buy rating on the stock with a $2.79 price target (25.3% upside potential).

Commenting on Valens’ acquisition of LYF Foods, Mir said, “Valens has secured entry onto BC retailer shelves through white labelling agreements with LPs/brands that not only provide Valens with immediate exposure to the edibles market, but also present opportunity to integrate Valens IP and cross-sell the company’s entire product portfolio.”

Overall, the consensus on the Street is that VLNCF is a Moderate Buy, based on 4 Buys and 1 Sell. The average analyst price target of $2.61 indicates an upside potential of about 17% from current levels. Shares have gained about 51.2% over the past year.

Related News:
QuickLogic Gains Over 5% On Distribution Agreement With Mouser
Maxeon Slips 6% On Weaker-Than-Expected 1Q Revenue Outlook
Leaf Shareholder Rejects Graham’s $8.50 Per Share Buyout Offer

Tags: ,
Kailas Salunkhe
Kailas has been writing stock news and analysis at TipRanks since 2021, and has worked in the financial domain in various roles since 2013. Prior to joining TipRanks, he served as an equity research analyst at Globflex Research, a quant fund, and Market Realist, an equity research firm, analyzing companies listed on the stock markets in the U.S., Europe, the Middle East, and Asia. Kailas has also worked as an equity trader, covering the U.S. stock markets, for Capstone Securities, a proprietary trading firm. Kailas' key strength lies in analyzing the pharmaceutical, biotech, and mining sectors and companies falling in their ambit. A proponent of long-term investing, he is also proficient in equity research, report writing, financial modeling, and pitch decks. Kailas believes that the law of compounding can work wonders for all investors if they ace the Marshmallow test.